Low-dose Methotrexate Therapy for Intravenous Immunoglobulin-resistant Kawasaki Disease
Open Access
- 1 January 2008
- journal article
- Published by XMLink in Yonsei Medical Journal
- Vol. 49 (5), 714-718
- https://doi.org/10.3349/ymj.2008.49.5.714
Abstract
Lee TJ, et al. Yonsei Med J. 2008 Oct;49(5):714-718. http://dx.doi.org/10.3349/ymj.2008.49.5.714Keywords
This publication has 14 references indexed in Scilit:
- Methotrexate modulates the kinetics of adenosine in humans in vivoAnnals Of The Rheumatic Diseases, 2006
- A Case of Intravenous Immunoglobulin-Resistant Kawasaki Disease Treated with MethotrexateYonsei Medical Journal, 2002
- Re‐treatment for immune globulin‐resistant Kawasaki disease: A comparative study of additional immune globulin and steroid pulse therapyPediatrics International, 2001
- Intravenous gamma-globulin treatment and retreatment in Kawasaki diseaseThe Pediatric Infectious Disease Journal, 1998
- Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroidsThe Journal of Pediatrics, 1996
- Gamma globulin re-treatment in Kawasaki diseaseThe Journal of Pediatrics, 1993
- Circulating Interleukin-1β in Patients with Kawasaki DiseaseThe New England Journal of Medicine, 1988
- Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki diseaseClinical Immunology and Immunopathology, 1988
- The Treatment of Kawasaki Syndrome with Intravenous Gamma GlobulinThe New England Journal of Medicine, 1986
- HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR KAWASAKI DISEASEThe Lancet, 1984